滚动资讯
FierceBiotechWhy Execution Excellence Now Defines Biopharma WinnersFierceBiotechHow integrated strategy is reshaping biopharma growthFierceBiotechBiotech value creation at an inflection pointFierceBiotechGSK pledges £44.5M in near-term for UK biotech to explore cause of liver fibrosis regressionPharmaVoice3 potential takeover targets in obesityFierceBiotechUnlearn 正在为临床开发构建科学智能层FierceBiotech人工智能如何重塑生物制药决策FierceBiotech生物医药IPO:时机、资本与灵活应对Roche Media罗氏与Nurix Therapeutics签署23亿美元血癌药物协议 - 制药技术Endpoints NewsIncyte公司以12.5亿美元预付款收购出血性疾病生物技术公司Vega TherapeuticsEndpoints News武田称艾米蒂莎反垄断裁决后将面临25亿美元损失,计划上诉Endpoints NewsNurix与罗氏达成合作,共同开发BTK降解剂,交易价值高达23亿美元

资讯库

总数 402
来源 Lonza News
搜索 --